(2-Chloro-6-methyl-pyrimidin-4-yl)-ethyl-amine, 1g

2-Methyl-5-(piperidin-1-ylsulfonyl)furan-3-carboxylic acid, 95%, 250mg

Colonne HPLC NUCLEODUR® 300-5 C4 ec, 250 mm, 4 mm, 1 pièce(s)

Mirtazepine, 98.0%, 1g

Methyl 3-iodo-1H-indazole-5-carboxylate, 97.0%, 10g

5-([1,1'-Biphenyl]-4-yl)-5,8-dihydroindolo[2,3-c]carbazole, 95%, 1g

6-Carboxyfluorescein, 95.0%, 100mg

4-Dodecyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene>98.0%(GC)1g

p-Tolyl Acetate>98.0%(GC)500g

5-Chloro-2-methoxypyridine>98.0%(GC)1g

N2-(1-(5-Amino-1,3,4-thiadiazol-2-yl)piperidin-4-yl)-1,3,4-thiadiazole-2,5-diamine, 250mg

N-[(1S,2S)-2-Amino-1,2-diphenylethyl]-1,1,1-trifluoromethanesulfonamide, 97%, 1g

4-(Tert-butyl)-1,2,3-thiadiazol-5-amine, 95%, 2.5g